NYSE · traded in Congress
Invesco Ltd IVZ
$27.601 +0.521 (+1.92%) Nov 9, 2026 4:04 AM ET
Market value$12.1B
P/E ratio-
Analyst target$36.00
52-week range-
Avg volume7,140,719
Dividend yield-
Chart
Analyst ratings
- 7 buy
- 11 hold
- 0 sell
Low target$31.00
Average target$35.07
High target$41.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $1,873M | - | - | - | |
| $1,826M | - | - | - | |
| $1,745M | - | - | - | |
| $1,692M | - | - | - |
Congress trades in IVZ
Members of Congress disclosed 2 transactions in IVZ in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 03/17/2026 | Kevin Hern OK01 | Sale | $15,001 - $50,000 | 4/3/2026 filing |
| 02/10/2026 | Gilbert Cisneros CA31 | Partial sale | $1,001 - $15,000 | 3/9/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
